Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Journal of Biological Response Modifiers

• Publication date

  1986-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 3958753
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon therapy in recurrent renal carcinoma.

  2009cited by this paper
• Unexpected toxicity from radiation therapy in two patients with Kaposi's sarcoma receiving interferon.

  1985cited by this paper
• Human leukocyte interferon as part of a combined treatment for previously untreated small cell lung cancer.

  1985cited by this paper
• Mechanisms of fever induced by recombinant human interferon.

  1984cited by this paper
• A radioimmunologic technique to screen for antibodies to alpha-2 interferon.

  1984cited by this paper
• Interferon-alpha therapy of renal cancer.

  1984cited by this paper
• Neurological effects of recombinant human interferon.

  1983cited by this paper
• Correlation between in vitro and systemic effects of native and recombinant interferons-alpha on human natural killer cell cytotoxicity.

  1983cited by this paper
• The treatment of renal cell carcinoma with human leukocyte alpha-interferon.

  1983cited by this paper
• Immunologic therapies of kidney carcinoma.

  1983cited by this paper
• Neurological effects of recombinant human interferon.

  1983cited by this paper
• Synthesis of intrathecal interferon in systemic lupus erythematosus with neurological complications.

  1983cited by this paper
• Immunological effects of recombinant interferon-alpha 2 in cancer patients.

  1983cited by this paper
• Renal cell carcinoma: antitumor effects of leukocyte interferon.

  1983cited by this paper
• An EORTC phase II study of methyl-glyoxal bis-guanylhydrazone in advanced renal cell cancer.

  1982cited by this paper
• Phase II study of medroxyprogesterone acetate with tamoxifen in advanced renal cell cancer.

  1982cited by this paper
• Current therapy for renal cell carcinoma.

  1982cited by this paper
• Hepatic dysfunction in renal carcinoma.

  1981cited by this paper
• Reporting results of cancer treatment

  1981cited by this paper
• At least three human type alpha interferons: structure of alpha 2.

  1980cited by this paper
• Renal cell carcinoma: natural history and results of treatment.

  1978cited by this paper
• Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate.

  1978cited by this paper
• Current status of the therapy of advanced renal carcinoma

  1977cited by this paper
• Preparation of human leukocyte interferon for clinical use.

  1977cited by this paper

• Immunotherapy for metastatic renal cell carcinoma.

  2017cites this paper
• WITHDRAWN: Immunotherapy for advanced renal cell cancer.

  2015cites this paper
• Immunotherapy for advanced renal cell cancer.

  2015cites this paper
• Potential of Interferon-α in Solid Tumours

  2012cites this paper
• Cancer immunotherapy.

  2011cites this paper
• Interferons and Interleukin-2: Molecular Basis of Activity and Therapeutic Results

  2009cites this paper
• Systemic Therapy for Metastatic Renal Cell Carcinoma: Cytokines

  2008cites this paper
• Cytokine-Based Therapy for Cancer

  2008cites this paper
• Phase I analysis of BCNU-impregnated biodegradable polymer wafers followed by systemic interferon alfa-2b in adults with recurrent glioblastoma multiforme

  2008cites this paper
• Novel approaches for cancer immunotherapy

  2008influential citation
• Cancer immunotherapy

  2006cites this paper
• Cytokine therapy: a standard of care for metastatic renal cell carcinoma?

  2005cites this paper
• Ifosfamide, vindesine and recombinant α-interferon combination chemotherapy for metastatic renal cell carcinoma

  2005cites this paper
• Rationale for immunotherapy of renal cell carcinoma

  2004cites this paper
• Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay

  2004cites this paper
• Potential of interferon-alpha in solid tumours: part 1.

  2002cites this paper
• Immunotherapy for advanced renal cell cancer.

  2000cites this paper
• Cytokine therapy in renal cell cancer.

  2000cites this paper
• Role of Interferon in Metastatic Renal Cell Carcinoma

  2000cites this paper
• Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer.

  1999cites this paper
• Continuous-infusion floxuridine and alpha interferon in metastatic renal cancer: a national biotherapy study group phase II study.

  1999cites this paper
• Prospective R andomized T rial o f I nterferon A lfa-2a P lus Vinblastine V ersus V inblastine A lone i n P atients With A dvanced R enal C ell C ancer

  1999cites this paper
• Cancer Biotherapy: 1998 Disease-Related Activity

  1998cites this paper
• Cyclic interferon alpha treatment in metastatic renal cell carcinoma: results of a phase II study and review of the literature.

  1997cites this paper
• Interferons in the Treatment of Genitourinary Tumors

  1997cites this paper
• Renal cell carcinoma and interleukin-2: a review.

  1995cites this paper
• Interferon-alpha and survival in renal cell cancer.

  1995cites this paper
• Tumours in Urology

  1994cites this paper
• The management of renal cell carcinoma.

  1994cites this paper
• Immunotherapy in the Management of Metastatic Renal Cell Carcinoma

  1994cites this paper
• Treatment of renal cell carcinoma with escalating doses of alpha-interferon.

  1993cites this paper
• [Immunotherapy of metastatic renal cell cancer].

  1993cites this paper
• Interferons and interleukins in metastatic renal cell carcinoma.

  1993cites this paper
• Immunotherapy for metastatic renal cell carcinoma.

  1993cites this paper
• Treatment of gastrointestinal and renal adenocarcinomas with interferon-alpha

  1992cites this paper
• Immunological effects of treatment with sequential administration of recombinant interferon gamma and alpha in patients with metastatic renal cell carcinoma during a phase I trial.

  1992cites this paper
• Immundiagnostik und Immuntherapie bei Kopf-Hals-Malignomen

  1992cites this paper
• Pharmacokinetic aspects of interferon alfa-2b after intrahepatic or intraperitoneal administration.

  1992cites this paper
• A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.

  1990cites this paper
• Role of interferons in the therapy of metastatic renal cell carcinoma.

  1989cites this paper
• An assessment of the current use of human interferons in therapy of urological cancers.

  1989cites this paper
• Oncogenes and growth factors.

  1988cites this paper
• Phase I study of recombinant methionyl human consensus interferon (r-metHuIFN-Con1).

  1988cites this paper
• Immunologische Aspekte in der Behandlung des Nierenkarzinoms

  1988cites this paper
• Combination of recombinant interferon alpha‐2A and vinblastine in advanced renal cell cancer

  1988cites this paper
• Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodies.

  1988cites this paper
• Postersitzung 4: Das metastasierte Nierenzellkarzinom

  1988cites this paper
• Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administration.

  1987cites this paper
• Interferon in renal cell carcinoma. The UCLA experience

  1987cites this paper